Setareh Seyedkazemi

CIK 1903088 · CHIEF DEVELOPMENT OFFICER · last filed 2025-12-10

Setareh Seyedkazemi is a CHIEF DEVELOPMENT OFFICER who has filed 13 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for ADVM, was dated Dec 10, 2025. Across all open-market trades the lifetime net is −$957, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

13

Lifetime Open-Market Net

-$957

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adverum Biotechnologies, Inc. (ADVM) Delisted CHIEF DEVELOPMENT OFFICER 0 $4.36 $0 -$957 13 2025-12-10

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-10 Adverum Biotechnologies, Inc. (ADVM) Delisted Mixed −66,331 $0 EDGAR
2025-06-20 Adverum Biotechnologies, Inc. (ADVM) Delisted Mixed $0 EDGAR
2025-05-16 Adverum Biotechnologies, Inc. (ADVM) Delisted Sell (S) −924 -$1.8K EDGAR
2025-02-27 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) +8,125 $0 EDGAR
2024-08-06 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2024-03-12 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2024-02-14 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2023-09-18 Adverum Biotechnologies, Inc. (ADVM) Delisted Sell (S) −6,201 -$9.4K EDGAR
2023-03-03 Adverum Biotechnologies, Inc. (ADVM) Delisted Grant (A) $0 EDGAR
2022-09-21 Adverum Biotechnologies, Inc. (ADVM) Delisted Sell (S) −6,058 -$6.5K EDGAR
Showing 110 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.